Knights of Columbus Asset Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-40,956	Closed	-$732K	–	345
2021 Q1	$732K	Hold	40,956	–	–	0.07%	255
2020 Q4	$553K	Hold	40,956	–	–	0.06%	274
2020 Q3	$482K	Hold	40,956	–	–	0.06%	263
2020 Q2	$605K	Hold	40,956	–	–	0.07%	275
2020 Q1	$553K	Hold	40,956	–	–	0.07%	298
2019 Q4	$990K	Buy	+40,956	New	+$848K	0.09%	322

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Knights of Columbus Asset Advisors's AERI Position: Q2 2021 in Review

Knights of Columbus Asset Advisors sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 40,956 shares — an estimated $732K sold.

Knights of Columbus Asset Advisors first reported a position in AERI in Q4 2019 and held it in 6 quarters. The position peaked at $990K in Q4 2019. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

Knights of Columbus Asset Advisors reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 40,956 Aerie Pharmaceuticals shares in Q2 2021, an estimated $732K.
Knights of Columbus Asset Advisors first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 6 quarters.
Knights of Columbus Asset Advisors's Aerie Pharmaceuticals position peaked at $990K in Q4 2019.
142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.